Closing Panel, • 9/22/25 Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Solutions for Trial Design Challenges in Rare Disease Trials Case Studies in Rare Disease Commercialization: Lessons Learned
Closing Panel, • 9/22/25 Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Solutions for Trial Design Challenges in Rare Disease Trials Case Studies in Rare Disease Commercialization: Lessons Learned
